Literature DB >> 8218050

Stage III macular hole surgery.

J Orellana1, R M Lieberman.   

Abstract

Twelve macular holes in 12 patients underwent a pars plana vitrectomy and epiretinal membrane resection with intravitreal gas tamponade for repair of their macular holes. The patients had stage III macular holes and had previously undergone a normal funduscopic examination within 2 years. The patients have been followed for a mean of 14 months (range 12-18 months) postoperatively. The results show that visual acuity improvements were not seen until at least 6 months after surgery if the hole was closed successfully. Seven holes were closed (58.3%) and all improved their best corrected visual acuity by more than two Snellen lines. In the five eyes that did not demonstrate hole closure (41.6%), one eye improved by two lines as well. The other four eyes remained at their preoperative acuity. One eye developed a dialysis which responded to a fluid air exchange and cryopexy (8.3%). Three eyes developed minimal lenticular opacities during the follow up period (25%). One eye demonstrated an altered perifoveal pigment epithelium perhaps related to intraoperative light toxicity. Macular hole surgery can restore some central acuity even in patients with longstanding holes.

Entities:  

Mesh:

Year:  1993        PMID: 8218050      PMCID: PMC513949          DOI: 10.1136/bjo.77.9.555

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  11 in total

1.  Vitreous surgery for macular hole in perspective. Is there an indication?

Authors:  S L Fine
Journal:  Arch Ophthalmol       Date:  1991-05

2.  Idiopathic senile macular hole. Its early stages and pathogenesis.

Authors:  J D Gass
Journal:  Arch Ophthalmol       Date:  1988-05

3.  Laser treatment of macular holes.

Authors:  S S Schocket; V Lakhanpal; X P Miao; S Kelman; E Billings
Journal:  Ophthalmology       Date:  1988-05       Impact factor: 12.079

4.  Surgical excision of the attached posterior hyaloid.

Authors:  D P Han; G W Abrams; T M Aaberg
Journal:  Arch Ophthalmol       Date:  1988-07

5.  Histopathologic features of idiopathic macular holes and cysts.

Authors:  D R Guyer; W R Green; S de Bustros; S L Fine
Journal:  Ophthalmology       Date:  1990-08       Impact factor: 12.079

6.  Vitreous surgery for idiopathic macular holes. Results of a pilot study.

Authors:  N E Kelly; R T Wendel
Journal:  Arch Ophthalmol       Date:  1991-05

7.  Cyanoacrylate tissue adhesive in the management of recurrent retinal detachment caused by macular hole.

Authors:  S M Sheta; T Hida; B W McCuen
Journal:  Am J Ophthalmol       Date:  1990-01-15       Impact factor: 5.258

8.  A histopathologic study of macular cysts and holes.

Authors:  G T Frangieh; W R Green; H M Engel
Journal:  Retina       Date:  1981       Impact factor: 4.256

9.  Involutional macular thinning. A pre-macular hole condition.

Authors:  C M Morgan; H Schatz
Journal:  Ophthalmology       Date:  1986-02       Impact factor: 12.079

10.  Transforming growth factor-beta 2 for the treatment of full-thickness macular holes. A prospective randomized study.

Authors:  B M Glaser; R G Michels; B D Kuppermann; R N Sjaarda; R A Pena
Journal:  Ophthalmology       Date:  1992-07       Impact factor: 12.079

View more
  8 in total

Review 1.  Idiopathic full thickness macular hole: natural history and pathogenesis.

Authors:  E Ezra
Journal:  Br J Ophthalmol       Date:  2001-01       Impact factor: 4.638

2.  Peripheral visual field loss after vitreous surgery for macular holes.

Authors:  S Bopp; K Lucke; U Hille
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-06       Impact factor: 3.117

3.  Macular holes: migratory gaps and vitreous as obstacles to glial closure.

Authors:  H D Schubert; K Kuang; F Kang; M W Head; J Fischbarg
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-08       Impact factor: 3.117

4.  Comparative evaluation of anatomical and functional outcomes using brilliant blue G versus triamcinolone assisted ILM peeling in macular hole surgery in Indian population.

Authors:  Atul Kumar; Varun Gogia; Vinit M Shah; Tapas C Nag
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-01-14       Impact factor: 3.117

5.  Natural outcomes of stage 1, 2, 3, and 4 idiopathic macular holes.

Authors:  T Hikichi; A Yoshida; J Akiba; C L Trempe
Journal:  Br J Ophthalmol       Date:  1995-06       Impact factor: 4.638

6.  Predicting visual outcome after macular hole surgery using scanning laser ophthalmoscope microperimetry.

Authors:  F Amari; K Ohta; H Kojima; N Yoshimura
Journal:  Br J Ophthalmol       Date:  2001-01       Impact factor: 4.638

7.  Visual field loss following vitrectomy for stage 2 and 3 macular holes.

Authors:  E Ezra; G B Arden; P Riordan-Eva; G W Aylward; Z J Gregor
Journal:  Br J Ophthalmol       Date:  1996-06       Impact factor: 4.638

8.  Comparison of macular function and visual fields after membrane blue or infracyanine green staining in vitreoretinal surgery.

Authors:  Katharina E Schmid-Kubista; Peggy D Lamar; Alexandra Schenk; Ulrike Stolba; Susanne Binder
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-10-13       Impact factor: 3.117

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.